Object memory enhancement by combining sub-efficacious doses of specific phosphodiesterase inhibitors

Keyphrases

• Phosphodiesterase Inhibitors 100%
• PDE 100%
• Memory Enhancement 100%
• Object Recognition Memory 100%
• Long-term Potentiation 50%
• Cyclic GMP 50%
• CAMP Signaling 50%
• Memory Consolidation 50%
• CGMP Signaling 50%
• Synaptic Memory 50%
• Consolidation Phase 50%
• Potential Treatments 25%
• Treatment Strategy 25%
• Memory Performance 25%
• Memory Decline 25%
• Memory Formation 25%
• Memory Processes 25%
• Synaptic Plasticity 25%
• Additive Effect 25%
• Therapeutic Implications 25%
• Combination Treatment 25%
• Rolipram 25%
• Object Recognition Task 25%
• Vardenafil 25%
• Long-term Plasticity 25%
• Hippocampal Slice 25%
• Cyclic nucleotides 25%
• Second Messenger 25%
• Type II Inhibitor 25%
• Dual Substrate 25%
• CAMP Phosphodiesterase 25%
• Type IV Inhibitors 25%
• Late-phase Long-term Potentiation 25%

Neuroscience

• Cyclic Guanosine Monophosphate 100%
• Object Memory 100%
• Phosphodiesterase Inhibitor 100%
• Long-Term Potentiation 60%
• Cyclic Adenosine Monophosphate 60%
• Synaptic Plasticity 40%
• Memory Consolidation 40%
• cAMP Signaling 40%
• Cyclic Nucleotide 20%
• Second Messenger System 20%
• Rolipram 20%
• Phosphodiesterase-4 Inhibitor 20%
• Vardenafil 20%

INIS

• doses 100%
• phosphodiesterases 100%
• partial differential equations 100%
• plasticity 50%
• administration 25%
• nucleotides 25%
• performance 25%
• additives 25%
• substrates 25%
• breakdown 25%